This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.
We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.
Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.
Resolved shortages
The following shortages have been resolved and supply has resumed to the Irish market:
Product | Active Ingredient(s) |
Atecor 50mg Tablets PA0711/003/002 Rowex Ltd | Atenolol |
Bendamustine HCl 100 mg Powder for Concentrate for Solution for Infusion PA2059/028/002 Fresenius Kabi Deutschland GmbH | Bendamustine |
CONBRIZA 20 mg Film Coated Tablets] EU/1/09/511/001 Pfizer Europe MA EEIG | Bazedoxifene |
Daktarin 2% w/w Cutaneous Powder PA0330/048/002 Johnson & Johnson (Ireland) Limited | Miconazole |
Dermovate 0.05% w/w Cream PA1077/005/001 GlaxoSmithKline (Ireland) Limited | Clobetasol |
Donepezil Krka 5mg Film Coated Tablets PA1347/014/003 KRKA, d.d., Novo mesto | Donepezil |
Estradot 100mcg/24 hours, Transdermal Patch PA0896/010/004 Novartis Ireland Limited | Estradiol |
Ezetimibe Krka 10mg Tablets PA1347/066/001 KRKA, d.d., Novo mesto | Ezetimibe |
Fental Matrix 25 micrograms/hour Transdermal Patch PA0711/146/001 Rowex Ltd | Fentanyl |
Flucloxacillin 1000mg Powder for solution for injection/infusion PA1862/003/003 Ibigen Srl | Flucloxacillin |
Fortum 1g Powder for Solution for Injection or Infusion PA23311/001/002 Sandoz Pharmaceuticals d.d. | Ceftazidime |
Lioresal 5mg/5ml Oral solution PA0896/017/002 Novartis Ireland Limited | Baclofen |
Lithium Chloride 0.15 mmol/ml. Solution for Injection PA23039/001/001 LiDCO Netherlands B.V | Lithium |
Mivacron 2mg/ml Solution for Injection (5ml presentation only) PA1691/031/001 Aspen Pharma Trading Limited | Mivacurium |
Montelukast Mylan 4mg Chewable Tablets PA0577/131/001 McDermott Laboratories Ltd., T/A Gerard Laboratories | Montelukast |
Norditropin FlexPro 15mg/1.5 ml, Solution for Injection PA0218/040/013 Novo Nordisk A/S | Norditropin |
Olanzapine Teva 10mg Orodispersible Tablet EU/1/07/427/027 Teva B.V. | Olanzapine |
Omeprazole Teva 10mg Gastro-Resistant Capsules PA0749/160/001 Teva Pharma B.V. | Omeprazole |
Optiray 350 mg I/ml solution for injection or infusion (500ml) PA0686/007/006 Guerbet | Ioversol |
Requip 0.25 mg Film Coated Tablets PA1077/037/001 GlaxoSmithKline (Ireland) Limited | Ropinirole |
Rhinolast 140 micrograms per Spray, Nasal Spray PA2010/037/001 Mylan IRE Healthcare Limited | Azelastine |
Valsartan Krka 80mg Film Coated Tablets PA1347/010/007 KRKA, d.d., Novo mesto | Valsartan |
Valsartan Mylan 80mg Film Coated Tablets PA0577/134/002 McDermott Laboratories Ltd., T/A Gerard Laboratories | Valsartan |
Newly notified shortages
The HPRA has been notified of a shortage of the following products:
Product | Active Ingredient(s) |
Amlodipine Teva 10mg Tablets PA0749/067/002 Teva Pharma B.V. | Amlodipine |
ARICEPT 5mg Film Coated Tablets PA0822/002/001 Pfizer Healthcare Ireland | Donepezil |
Atecor 100mg Tablets PA0711/003/003 Rowex Ltd | Atenolol |
Bendamustine 25mg Powder for Concentrate for Solution for Infusion PA1986/121/001 Teva B.V. | Bendamustine |
Carboplatin-Teva 10mg/ml Concentrate for Solution for Infusion (600mg presentation) PA0749/004/001 Teva Pharma B.V. | Carboplatin |
Co-amoxiclav 1000mg/200mg Powder for Solution for Injection/Infusion PA2220/002/002 Instituto Biochimico Italiano G. Lorenzini S.p.A. | Amoxicillin & clavulanic acid |
Crystapen 600mg Powder for Solution for Injection or Infusion PA0126/313/001 Clonmel Healthcare Ltd | Benzylpenicillin |
Drynol 20mg Tablets PA0865/018/001 Menarini International Operations Luxembourg S.A. | Bilastine |
Ezetimibe Rowa 10mg Tablets PA0074/074/001 Rowa Pharmaceuticals Limited | Ezetimibe |
Foznol 750mg Chewable Tablets PA23211/002/003 Takeda Pharmaceuticals International AG Ireland Branch | Lanthanum |
Fucidin 20 mg/g Cream PA0046/004/012 Leo Laboratories Limited | Fusidic acid |
Fucithalmic 10mg/g Viscous Eye Drops, Suspension PA1142/016/001 Amdipharm Limited | Fusidic acid |
INSPRA 25mg Film Coated Tablets PA23055/005/001 Upjohn EESV | Eplerenone |
Lansoprazole Teva Pharma 15mg Gastro-resistant Capsules, Hard PA1986/008/001 Teva B.V. | Lansoprazole |
Ritalin LA 30mg prolonged-release capsules PA1972/002/003 InfectoPharm Arzneimittel und Consilium GmbH | Methylphenidate |
NASONEX 50 micrograms/actuation Nasal Spray, Suspension PA23198/011/001 Organon Pharma (Ireland) Limited | Mometasone |
Neurostil 300mg Capsules, Hard PA0749/164/002 Teva Pharma B.V. | Gabapentin |
Rosuvastatin Krka 5mg Film Coated Tablets PA1347/016/001 KRKA, d.d., Novo mesto | Rosuvastatin |
Rosuvastatin Krka 20mg Film Coated Tablets PA1347/016/003 KRKA, d.d., Novo mesto | Rosuvastatin |
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.